iodixanol has been researched along with allopurinol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Basir, I; Bouwman, E; van der Burg, MP | 1 |
| Bo, W; Chao, Z; Haitao, Z; Liang, Y; Min, T; Wei, W; Yi, L | 1 |
3 other study(ies) available for iodixanol and allopurinol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
No porcine islet loss during density gradient purification in a novel iodixanol in University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Animals; Cell Separation; Centrifugation, Density Gradient; Glutathione; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Organ Preservation Solutions; Raffinose; Swine; Triiodobenzoic Acids | 1998 |
Superiority of visipaque (iodixanol)-controlled density gradient over Ficoll-400 in adult porcine islet purification.
Topics: Adenosine; Allopurinol; Animals; Blood Glucose; Cell Count; Cell Separation; Cell Survival; Contrast Media; Diabetes Mellitus, Experimental; Ficoll; Glutathione; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Organ Preservation Solutions; Raffinose; Rats; Rats, Sprague-Dawley; Swine; Transplantation, Heterologous; Triiodobenzoic Acids | 2010 |